机构：[1]Department of Nephrology, Shenzhen Second People's Hospital, the First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, P.R. China深圳市第二人民医院深圳市康宁医院深圳医学信息中心[2]Shantou University Medical College, Shantou, Guangdong, P.R. China.[3]Department of Epidemiology and Biostatistics, Empower U, X&Y solutions Inc., Boston, Massachusetts, USA[4]Department of Immunology and Microbiology, Guiyang College of Traditional Chinese Medicine, Guiyang, Guizhou, China
This work was supported by a grant from the Basic Research Program of the Shenzhen Science and
Technology R & D Fund (Grant No. JCYJ20190806163801637), Shenzhen Second People’s Hospital
Clinical Research Fund of Guangdong Province High-level Hospital Construction Project (Grant No.
20203357012), Shenzhen Key Medical Discipline Construction Fund (Grant No. SZXK009).
第一作者机构：[1]Department of Nephrology, Shenzhen Second People's Hospital, the First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, P.R. China
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Cheng Yuan,Xiang Qiong,Cao Tao,et al.Suppression of thyroid profile during roxadustat treatment in chronic kidney disease patients[J].NEPHROLOGY DIALYSIS TRANSPLANTATION.2023,38(6):1567-1570.doi:10.1093/ndt/gfad017.
APA：
Cheng Yuan,Xiang Qiong,Cao Tao,Tang Fei,Chen Jia...&Wan Qijun.(2023).Suppression of thyroid profile during roxadustat treatment in chronic kidney disease patients.NEPHROLOGY DIALYSIS TRANSPLANTATION,38,(6)
MLA：
Cheng Yuan,et al."Suppression of thyroid profile during roxadustat treatment in chronic kidney disease patients".NEPHROLOGY DIALYSIS TRANSPLANTATION 38..6(2023):1567-1570
医学